Here is a comprehensive review of Ms. Pallavi's routine check-up report (Age 40, Female | Collected: 19 May 2026 | Dr Lal PathLabs):
π΄ ABNORMAL FINDINGS β Needs Attention
1. Iron Deficiency Anemia (Most Significant Finding)
| Parameter | Result | Reference | Status |
|---|
| Hemoglobin | 11.90 g/dL | 12.00β15.00 | β¬οΈ Low |
| PCV | 35.20% | 36β46% | β¬οΈ Low |
| MCV | 79.10 fL | 83β101 fL | β¬οΈ Low (microcytic) |
| MCH | 26.70 pg | 27β32 pg | β¬οΈ Low |
| RDW | 15.30% | 11.60β14.00% | β¬οΈ High |
| Serum Iron | 34.50 Β΅g/dL | 50β170 Β΅g/dL | β¬οΈ Very low |
| TIBC | 429.80 Β΅g/dL | 250β425 Β΅g/dL | β¬οΈ High |
| Transferrin Saturation | 8.03% | 15β50% | β¬οΈ Very low |
| Mentzer Index | 17.7 | >13 β IDA | β
Consistent with IDA |
Interpretation: Classic iron deficiency anemia β low Hb, microcytic (low MCV), low iron, elevated TIBC, very low transferrin saturation, and high RDW. The Mentzer Index of 17.7 (>13) supports Iron Deficiency Anemia over beta-thalassemia trait.
Action: Iron supplementation (oral ferrous sulfate/ferrous ascorbate) is indicated. The referring doctor should investigate the cause of iron deficiency (dietary, menstrual losses, GI bleeding, malabsorption).
2. Liver Enzymes β Mildly Elevated
| Parameter | Result | Reference | Status |
|---|
| AST (SGOT) | 44.3 U/L | <35 U/L | β¬οΈ High |
| ALT (SGPT) | 51.7 U/L | <35 U/L | β¬οΈ High |
| GGTP | 39.2 U/L | <38 U/L | β¬οΈ Marginally high |
| Bilirubin Total | 1.41 mg/dL | 0.30β1.20 | β¬οΈ High |
| Bilirubin Direct | 0.25 mg/dL | <0.20 | β¬οΈ Slightly high |
| Bilirubin Indirect | 1.16 mg/dL | <1.10 | β¬οΈ Slightly high |
Interpretation: Mild transaminitis (AST+ALT both ~1.3β1.5Γ upper limit). AST:ALT ratio of 0.86 (<1) suggests a hepatocellular rather than alcoholic pattern. Could be early NAFLD (non-alcoholic fatty liver disease), medication effect, or related to the underlying iron deficiency. Globulin is also mildly elevated (4.04 vs. 2.0β3.5 g/dL) which may suggest chronic inflammation.
Action: Clinical correlation, consider hepatitis B/C serology, liver ultrasound if not recently done. Repeat LFTs in 4β6 weeks.
3. Lipid Profile β Elevated LDL
| Parameter | Result | Reference | Status |
|---|
| Total Cholesterol | 205 mg/dL | <200 | β¬οΈ Borderline high |
| LDL Cholesterol | 134.2 mg/dL | <100 | β¬οΈ High |
| Non-HDL Cholesterol | 152 mg/dL | <130 | β¬οΈ High |
| HDL | 52.9 mg/dL | >50 | β
Normal |
| Triglycerides | 89.5 mg/dL | <150 | β
Normal |
Interpretation: LDL is significantly above the <100 mg/dL target. As per Lipid Association of India 2020, if she is in the moderate risk category (no known CVD/diabetes), goal is LDL <100 mg/dL and non-HDL <130 mg/dL. She currently exceeds both targets.
Action: Lifestyle intervention first β low saturated fat diet, increased physical activity. If no improvement after 3 months, pharmacological therapy (statin) may be warranted.
4. Serum Amylase β Mildly Elevated
| Parameter | Result | Reference | Status |
|---|
| Amylase | 101 U/L | 28β100 U/L | β¬οΈ Marginally high |
Interpretation: Just 1 unit above the upper limit. Mildly elevated amylase can occur with minor salivary gland irritation, gastroenteritis, or medications. Acute pancreatitis typically shows values >3Γ ULN.
Action: Clinical correlation. If no abdominal symptoms, likely not significant. Repeat if symptoms develop.
5. hsCRP β Average Cardiovascular Risk
| Parameter | Result | Reference | Status |
|---|
| hsCRP | 1.64 mg/L | <1.00 | β¬οΈ Average risk zone (1β3) |
Interpretation: Falls in the "average" cardiovascular risk zone (1β3 mg/L). Likely related to the underlying anemia/inflammation. Not alarming but should be monitored alongside the lipid findings.
6. Urine β Possible Early UTI
| Parameter | Result | Reference | Status |
|---|
| Leucocyte Esterase | 1+ (25 WBC/Β΅L) | Negative | β¬οΈ Positive |
| Pus Cells | 6β8 WBC/HPF | 0β5 | β¬οΈ High |
| Protein | Traces | Negative | β¬οΈ Trace |
| Nitrite | Negative | Negative | β
Normal |
Interpretation: Elevated pus cells with positive leucocyte esterase suggests asymptomatic bacteriuria or a mild UTI, though nitrite is negative. This can occur with contamination in women or early infection.
Action: If Ms. Pallavi has urinary symptoms (burning, frequency), a urine culture (C&S) should be ordered. If asymptomatic, repeat urinalysis after proper mid-stream collection.
β
NORMAL / REASSURING FINDINGS
| Parameter | Result | Status |
|---|
| Kidney function (Creatinine, Urea, Uric Acid) | All normal | β
|
| eGFR | 114 mL/min/1.73mΒ² (G1 β Optimal) | β
|
| Fasting Glucose | 81.3 mg/dL | β
|
| HbA1c | 5.1% | β
Non-diabetic |
| Thyroid (T3, T4, TSH) | All within normal range | β
|
| Vitamin D | 82.53 nmol/L (Sufficient >75) | β
|
| Vitamin B12 | 268 pg/mL (Normal) | β
|
| Calcium, Phosphorus, Electrolytes | All normal | β
|
| Apolipoproteins A1 & B, ApoB/ApoA1 ratio | All within normal range | β
|
| WBC count & differential | Normal | β
|
| Platelet count | 263 thou/mmΒ³ | β
|
| ESR | 19 mm/hr | β
|
Summary & Priority Actions for Dr. Pravesh Gupta
- Iron Deficiency Anemia β Start iron supplementation; investigate underlying cause (menstrual history, dietary intake, GI bleeding)
- Mild Transaminitis β Hepatitis serology, consider liver ultrasound; repeat LFTs in 4β6 weeks
- Elevated LDL β Dietary modifications first; reassess lipid profile in 3 months
- Urine findings β Rule out UTI, repeat urinalysis with proper sample collection
- Amylase & hsCRP β Mildly elevated; clinical correlation needed; no immediate action if asymptomatic
β οΈ This is an AI-assisted interpretation for informational purposes. All clinical decisions must be made by the referring physician (Dr. Pravesh Gupta) in the context of the patient's full clinical history.